Elixirr International – Is This Consultancy Ready To Grow?
Mark Watson-Mitchell thinks this group is firmly on course to meet its $1 billion ambitions.
2 years ago
Equities
Small Cap Round-Up: Digital Developments
Mark Watson-Mitchell looks at Restore, Filtronic, CentralNic and NCC.
2 years ago
Small-Cap Update: One Fizzing Up and Running Out Of Gas
Mark Watson-Mitchell responds to news from two companies heading in different directions.
2 years ago
H&T Group – Trash or Treasure?
Mark Watson-Mitchell reckons now is the time to jump in on this pawnbroker after the price fallback of the last…
2 years ago
Hybridan Small Cap Feast
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
2 years ago
Small Cap catch-up highlighting Time Finance, TClarke and more
Mark Watson-Mitchell closes out the week with a look at a range of his favourite shares.
2 years ago
Pharmaceuticals and Biotech Are Due For a Rebound
Over the last year, defensive stocks have done very well relative to the broad market. Sectors including Health Care, Utilities…
2 years ago
Sureserve Group – Time To Reassess After Results?
Mark Watson-Mitchell believes that this firm's strong order book, cash position and increasing profits exposes undervalued of its shares.
2 years ago
CentralNic – Looking Ahead To Q4 Results
Mark Watson-Mitchell explains why you shouldn't underestimate this group’s potential as he sets a new target price.
2 years ago
Ad Astra: SpaceX versus Tesla
SpaceX will soon be worth more than Tesla. Elon, we still love you – despite your poor corporate governance, declares…
2 years ago